From: Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study
Total (n = 34) | MEPE vs non-MEPE | Peripheral eosinophilia vs normal peripheral eosinophil | |||||
---|---|---|---|---|---|---|---|
MEPE (n = 18) | Non-MEPE (n = 16) | p-Value | Peripheral eosinophilia (n = 9) | Normal peripheral eosinophil (n = 25) | p-Value | ||
Age (y) | 56.4 (25–88) | 61.7 (44–88) | 50.5 (25–83) | 0.03 | 51.7 (25–74) | 58.1 (29–88) | 0.36 |
Sex | 0.774 | 0.70 | |||||
Male | 20 (58.82%) | 11 (61.11%) | 9 (77.8%) | 6 (66.7%) | 14 (56.0%) | ||
Female | 14 (41.18%) | 7 (38.89%) | 7 (22.2%) | 3 (33.3%) | 11 (44.0%) | ||
Peripheral blood | |||||||
WBC (× 109/L) | 8.6 (3.2–21.4) | 8.5 (3.2–21.4) | 8.8 (4.6–16.7) | 0.87 | 10.1 (4.7–16.7) | 8.1 (3.2–21.4) | 0.04 |
LYM (× 109/L) | 1.3 (0.3–2.5) | 1.4 (0.6–2.5) | 1.2 (0.3–2.4) | 0.26 | 1.5 (0.3–2.4) | 1.2 (0.5–2.5) | 0.13 |
EO (× 106/L) | 514.7 (0–5778.0) | 394.4 (0–1500.0) | 661.2 (0–5778.0) | 0.44 | 1378.0 (600–5778.0) | 204.0 (0–500) | < 0.001 |
Pleural effusion | |||||||
LDH (U/L) | 369 (90–1402) | 449 (172–1402) | 280 (90–667) | 0.09 | 437 (128–1126) | 345 (90- 1402) | 0.51 |
GLU (mmol/L) | 6.07 (3.02–9.77) | 6.50 (4.32–9.77) | 5.60 (3.02–8.0) | 0.12 | 5.93 (3.02–9.77) | 6.12 (3.19–8.34) | 0.54 |
Protein (g/L) | 48.0 (27.5–182.9) | 55.4 (35.2–182.9) | 39.7 (27.5–53.4) | 0.07 | 45.8 (32.8–62.3) | 48.8 (27.5–182.9) | 0.73 |
ADA (U/L) | 10.4 (0.1–44.7) | 8.4 (3.0–29.3) | 12.6 (0.1–44.7) | 0.24 | 10.4 (2.8–29.3) | 10.4 (0.1–44.7) | 0.79 |
CEA (ng/mL) | 106.4 (0.3–2087.0) | 199.0 (0.5–2087.0) | 2.2 (0.3–4.8) | 0.11 | 24.9 (0.30–162.2) | 135.7 (1.0–2087.0) | 0.32 |
WBC (× 109/L) | 3.2 (0.1–12.9) | 1.8 (0.1–7.67) | 4.7 (0.3–12.9) | 0.01 | 5.01 (0.3–12.9) | 2.50 (0.1–7.4) | 0.10 |
EO (%) | 21.7 (10.0–67.5) | 20.6 (10.0–63.0) | 22.9 (11.6–67.5) | 0.66 | 31.8 (11.0–67.5) | 18.1 (10–46.5) | 0.16 |
RBC (× 109/L) | 111.2 (0.2–2986.7) | 41.0 (0.2–320) | 190.3 (0.2–2986.7) | 0.40 | 27.9 (0.2–216.2) | 141.3 (0.2–2986.7) | 0.14 |